Next Wave in Immune Therapeutics: From suppression to re-balancing the immune systemJoin event
|Date & Time||September 29-30, 2020|
On 29-30 September 2020, Johnson & Johnson Innovation will host a virtual scientific and partnering event on state-of-the-art developments in immunology, bringing together entrepreneurs, start-ups, researchers, and scientists from across EMEA and beyond.
Immunology is one of the most rapidly advancing fields of biomedical research. Discoveries in immunology have enabled better ways to treat autoimmune and inflammatory conditions such as rheumatoid arthritis, inflammatory bowel disease and psoriasis. Despite these advances, only a ~16% of patients living with moderate to severe forms of immune-mediated diseases are treated with advanced therapies and less than half of those achieve clinical remission.
Get in touch with us
Chris Tieken, EATRIS Business Development Manager, will participate in this partnering virtual event. Get in touch with him and find out how EATRIS can help you accelerate your translational project and reach patients faster.